Karunakar et al. stated there was a difference in protein level and subcellular location of BCL3 between neoplastic tissues and adjacent normal tissue from the same colon cancer patients, and pointed out that analysis of the subcellular localization of BCL3 could be a potential-early diagnostic marker in colon cancer [23]. This evidence concerns the gene BCL3 and malignant colon neoplasm.